Details of the Drug-Related molecule(s) Interaction Atlas

BDBM50434165 Drug Info

CHEMBL2385271; SCHEMBL15129912; BDBM50434165

Cross-matching ID

PubChem CID

71667377

TTD Drug ID

DMDTYJ9

General Information of Drug (ID: DMDTYJ9)

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Patented Agent(s)

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Dipeptidyl-peptidase 7 (DPP7)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
BDBM50382283	DMQJ5S8	N. A.	N. A.	Patented	[1]
BDBM50434164	DM6DFTX	N. A.	N. A.	Patented	[1]
US8470836, 5	DMYR10P	N. A.	N. A.	Patented	[2]
US8470836, 8	DMM4GLH	N. A.	N. A.	Patented	[2]
CRWCYVOHVXAEMF-LBPRGKRZSA-N	DMBV5Z0	N. A.	N. A.	Patented	[1]
US8470836, 2	DMH7JVA	N. A.	N. A.	Patented	[2]
US8470836, 6	DMVYQXH	N. A.	N. A.	Patented	[2]
N4-(4-chlorobenzyl)-2,4-diaminobutanoylpiperidine	DMARZHU	Discovery agent	N.A.	Investigative	[3]
------------------------------------------------------------------------------------


⏷ Show the Full List of 8 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	FAP inhibitors. US9346814.
2	Dipeptidyl peptidase-IV inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as active agent. US8470836.
3	Dipeptidyl peptidase II and leukocyte cell death. Biochem Pharmacol. 2006 Jun 28;72(1):70-9.